Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04836156
Status:
RECRUITING
Last Update Posted:
2022-04-06
First Post:
2021-03-28
Brief Title:
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 HER2 Negative Early Breast Cancer Patients
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-28
First Submit QC Date:
April 5 2021
Study First Post Date:
2021-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-27
Last Update Post Date:
2022-04-06
Last Update Post Date Type:
ACTUAL